158
Replication and Clonal Amplification of Compartmentalized HIV-1 Populations in the Cerebrospinal Fluid of Subjects with HIV-associated Dementia
Gretja Schnell*1, R Price2, S Spudich2, and R Swanstrom1
1Univ of North Carolina at Chapel Hill, US and 2San Francisco Gen Hosp, Univ of California, San Francisco, US
Background: HIV-1 infection of the central nervous
system (CNS) can lead to neurological complications, including the development
of HIV-associated dementia (HAD). A subset of infected individuals develop HAD,
but it is not known to what extent independent replication and evolution of
HIV-1 in the CNS is a factor in CNS pathogenesis.
Methods: Viral genetic compartmentalization was
examined by conducting single genome amplification on the env gene from
cross-sectional and longitudinal plasma and cerebrospinal fluid (CSF) samples
from human subjects with varying degrees of neurological disease. The polymerase
chain reaction (PCR) amplicons were sequenced, aligned, and maximum-likelihood
phylogenetic trees were generated using PHYML.
Results: Phylogenetic analysis of virus obtained
from subjects with HAD (n = 7) and MCMD (n = 1) revealed trees with large
bifurcations and deep branch points separating virus from the plasma and the
CSF. In addition, clonal amplification of viral variants was detected in the
CSF of subjects with neurological disease, including one primary infection
subject. In subjects with neurological disease that were analyzed
longitudinally (n = 3), the virus population that was selectively amplified
changed over time. Asymptomatic subjects (n = 4) did not show a prominent
division between plasma and CSF virus. We did not detect a correlation between
neurological disease state and the presence of the N283 envelope variant or the
loss of a glycosylation site at position 386.
Conclusions: Deep bifurcations in the phylogenetic
trees from subjects with HAD and MCMD indicate that sustained HIV-1 replication
is occurring in the CNS of subjects with neurological disease, which is not
seen in asymptomatic subjects. In addition, we detected 2 distinct stages of
clonal amplification of virus in the CSF of subjects with neurological disease.
Prior to late stage disease, clonal amplification is detected for CSF HIV-1
variants that are similar to plasma virus. This represents CNS virus that is
newly seeded from the plasma, and indicates the first stage of immunodeficiency
when there is a sporadic loss of immune control. During late stage disease,
clonal amplification occurs in CSF variants that are separated phylogenetically
from plasma virus, indicating viral growth and increased HIV-1 replication in
the CNS, possibly due to virus seeding a previously uninfected anatomical
location.
|